Your browser doesn't support javascript.
loading
Consensus on surgical technique for sentinel lymph node dissection in cervical cancer.
Bizzarri, Nicolò; Obermair, Andreas; Hsu, Heng-Cheng; Chacon, Enrique; Collins, Anna; Tsibulak, Irina; Mutombo, Alex; Abu-Rustum, Nadeem R; Balaya, Vincent; Buda, Alessandro; Cibula, David; Covens, Allan; Fanfani, Francesco; Ferron, Gwenaël; Frumovitz, Michael; Guani, Benedetta; Kocian, Roman; Kohler, Christhardt; Leblanc, Eric; Lecuru, Fabrice; Leitao, Mario M; Mathevet, Patrice; Mueller, Michael D; Papadia, Andrea; Pareja, Rene; Plante, Marie; Querleu, Denis; Scambia, Giovanni; Tanner, Edward; Zapardiel, Ignacio; Garcia, Jaime R; Ramirez, Pedro T.
Affiliation
  • Bizzarri N; UOC Ginecologia Oncologica, Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy nicolo.bizzarri@yahoo.com.
  • Obermair A; Queensland Centre for Gynaecological Cancer Research, Faculty of Medicine, Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia.
  • Hsu HC; Obstetrics and Gynaecology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.
  • Chacon E; Gynaecologic Oncology, Universidad de Navarra, Pamplona, Spain.
  • Collins A; Obstetrics and Gynaecology, Derby Hospitals NHS Foundation Trust, Derby, UK.
  • Tsibulak I; Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Innsbruck, Austria.
  • Mutombo A; Gynaecology and Obstetrics, University of Kinshasa, Kinshasa, Congo (Democratic Republic of the).
  • Abu-Rustum NR; Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
  • Balaya V; Department of Obstetrics and Gynaecology, Felix Guyon Hospital, CHU Nord Réunion, France.
  • Buda A; Gynaecologic Oncology, Ospedale Michele e Pietro Ferrero, Verduno, Italy.
  • Cibula D; Department of Obstetrics and Gynecology, Charles University, First Faculty of Medicine, Prague, Czech Republic.
  • Covens A; Gynecologic Oncology, Toronto Sunnybrook Regional Cancer Center, Toronto, Ontario, Canada.
  • Fanfani F; UOC Ginecologia Oncologica, Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Ferron G; Department of Surgical Oncology, Institut Claudius Regaud Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
  • Frumovitz M; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Guani B; Department of Obstetrics and Gynaecology, Fribourg Hospitals, Fribourg, Switzerland.
  • Kocian R; Department of Obstetrics and Gynecology, Charles University, First Faculty of Medicine, Prague, Czech Republic.
  • Kohler C; Department of Gynaecology, University of Cologne, Koln, Germany.
  • Leblanc E; Department of Special Operative and Oncologic Gynaecology, Asklepios-Clinic Hamburg-Altona, Asklepios Hospital Group, Hamburg, Germany.
  • Lecuru F; Department of Surgical Oncology, Centre Oscar Lambret, Lille, France.
  • Leitao MM; Breast, Gynaecology, and Reconstructive Surgery Unit, Institute Curie, Paris, France.
  • Mathevet P; Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
  • Mueller MD; Centre Hospitalier Universitaire Vaudois Departement de gynecologie-obstetrique et genetique medicale, Lausanne, Switzerland.
  • Papadia A; Gynaecology and Gynaecological Oncology, Inselspital University Hospital Berne Department of Gynaecology, Bern, Switzerland.
  • Pareja R; Department of Gynaecology and Obstetrics, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Plante M; Università della Svizzera italiana, Lugano, Switzerland.
  • Querleu D; Department of Gynaecology, Gynaecologic Oncology, Clinica Astorga, Medellin, Colombia.
  • Scambia G; Instituto Nacional de Cancerología, Bogotá, Colombia.
  • Tanner E; Laval University, Quebec City, Quebec, Canada.
  • Zapardiel I; UOC Ginecologia Oncologica, Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Garcia JR; UOC Ginecologia Oncologica, Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Ramirez PT; Department of Obstetrics and Gynecology, Northwestern University, Evanston, Illinois, USA.
Int J Gynecol Cancer ; 34(4): 504-509, 2024 Apr 01.
Article in En | MEDLINE | ID: mdl-38378695
ABSTRACT

OBJECTIVE:

The purpose of this study was to establish a consensus on the surgical technique for sentinel lymph node (SLN) dissection in cervical cancer.

METHODS:

A 26 question survey was emailed to international expert gynecological oncology surgeons. A two-step modified Delphi method was used to establish consensus. After a first round of online survey, the questions were amended and a second round, along with semistructured interviews was performed. Consensus was defined using a 70% cut-off for agreement.

RESULTS:

Twenty-five of 38 (65.8%) experts responded to the first and second rounds of the online survey. Agreement ≥70% was reached for 13 (50.0%) questions in the first round and for 15 (57.7%) in the final round. Consensus agreement identified 15 recommended, three optional, and five not recommended steps. Experts agreed on the following recommended procedures use of indocyanine green as a tracer; superficial (with or without deep) injection at 3 and 9 o'clock; injection at the margins of uninvolved mucosa avoiding vaginal fornices; grasping the cervix with forceps only in part of the cervix is free of tumor; use of a minimally invasive approach for SLN biopsy in the case of simple trachelectomy/conization; identification of the ureter, obliterated umbilical artery, and external iliac vessels before SLN excision; commencing the dissection at the level of the uterine artery and continuing laterally; and completing dissection in one hemi-pelvis before proceeding to the contralateral side. Consensus was also reached in recommending against injection at 6 and 12 o'clock, and injection directly into the tumor in cases of the tumor completely replacing the cervix; against removal of nodes through port without protective maneuvers; absence of an ultrastaging protocol; and against modifying tracer concentration at the time of re-injection after mapping failure.

CONCLUSION:

Recommended, optional, and not recommended steps of SLN dissection in cervical cancer have been identified based on consensus among international experts. These represent a surgical guide that may be used by surgeons in clinical trials and for quality assurance in routine practice.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms Limits: Female / Humans Language: En Journal: Int J Gynecol Cancer Journal subject: GINECOLOGIA / NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Italia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms Limits: Female / Humans Language: En Journal: Int J Gynecol Cancer Journal subject: GINECOLOGIA / NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Italia